Hema Tallman Congratulates Richard Wilner on Receiving the Sustainability in Life Sciences Award
Hema Tallman, SVP- Global Head of BioLife Plasma Services at Takeda, shared on LinkedIn:
”Please join me in congratulating Richard Wilner, Head of Transformation and Sustainability at BioLife Plasma Services, part of Takeda, for receiving the Sustainability in Life Sciences Award at the 4th Annual Life Sciences Leadership Summit hosted by Campana and Schott USA and the German American Chamber of Commerce, Inc. – GACC New York.
Rich, along with the collective efforts of cross-functional teams, has helped shape BioLife’s contributions to reaching Takeda’s environmental goals:
– Reach net-zero greenhouse gas emissions in operations by 2035.
– Reach net-zero greenhouse gas emissions across our entire value chain by 2040.
– Send zero waste to landfill by 2030.
I’ve had the privilege of working alongside Rich, and I’m continually inspired by his bold thinking and his ability to foster innovation that spurs action.
Thank you, Rich, for your tireless passion and being a champion of meaningful change across our organization and industry and for our patients.”
Stay updated with Hemostasis Today.
-
May 27, 2026, 04:47Daniel Torrent: The Overlooked Epidemic of Post-Thrombotic Syndrome
-
May 27, 2026, 04:45Graziella Pompei: Is Aspirin Still a Valid Alternative to Clopidogrel in PCI with DES Implantation?
-
May 27, 2026, 04:40Kausik Ray: Phase 1 Trial Highlights Anti-Inflammatory Effects of Ruvonoflast
-
May 27, 2026, 04:29Francisco Chacón-Lozsán: High-Sensitivity Troponin and the Evolving Management of NSTEMI
-
May 27, 2026, 04:14Michael R. Jaff: HI-PEITHO Trial and NEWS Score Insights on Advances for Intermediate-Risk Pulmonary Embolism
-
May 26, 2026, 16:45Ashley George: Take the Leap for Thrombosis UK
-
May 26, 2026, 16:40Hamed Helisaz: Machine Learning for Detecting Missing Heart Medications
-
May 26, 2026, 15:32Haroun Gajraj: Brown Marks After Microsclerotherapy – What Every Practitioner Needs to Know
-
May 26, 2026, 15:29Jacqueline van Paassen: Lack of Essential Clinical Data in DOAC Prescriptions in Community Pharmacies